Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.
暂无分享,去创建一个
A. Smit | P. Quax | G. Hospers | W. Sluiter | R. Tio | J. Hooymans | N. Mulder | R. Dullaart | R. Gans | N. Mulder | Y. Kusumanto | V. van Weel | J. J. van den Dungen | V. V. Weel | Y. Kusumanto | P. Quax | Jjam van den Dungen | Paul H.A. Quax
[1] Sunyoung Kim,et al. Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease , 2004, Experimental & Molecular Medicine.
[2] A. Eskelinen,et al. Lower limb amputations in Southern Finland in 2000 and trends up to 2001. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[3] M. Railo,et al. Ankle Brachial Index Measurements in Critical Leg Ischaemia — The Influence of Experience on Reproducibility , 2003, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.
[4] Douglas Losordo,et al. Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemia. , 2003, Current pharmaceutical design.
[5] K. Shyu,et al. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. , 2003, The American journal of medicine.
[6] N. Mulder,et al. Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review , 2003, International journal of cardiovascular interventions.
[7] J. Pelisek,et al. Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs. , 2002, Acta physiologica Scandinavica.
[8] S. Ylä-Herttuala,et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[9] C. Sylvén,et al. Effects of intramyocardial injection of phVEGF‐A165 as sole therapy in patients with refractory coronary artery disease – 12‐month follow‐up: Angiogenic gene therapy , 2001, Journal of internal medicine.
[10] F. Gottrup,et al. A new concept of a multidisciplinary wound healing center and a national expert function of wound healing. , 2001, Archives of surgery.
[11] J. Groothoff,et al. Quality of life in patients with diabetic foot ulcers. , 2001, Disability and rehabilitation.
[12] J. Isner,et al. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. , 2001, Archives of neurology.
[13] P. Holstein,et al. Decreasing incidence of major amputations in people with diabetes , 2000, Diabetologia.
[14] Stephen W. K. Cheng,et al. Survival in Patients with Chronic Lower Extremity Ischemia: A Risk Factor Analysis , 2000, Annals of vascular surgery.
[15] I. Hallberg,et al. The effects of successful intervention on quality of life in patients with varying degrees of lower-limb ischaemia. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[16] J. Isner,et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. , 1998, Journal of vascular surgery.
[17] K Walsh,et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.
[18] R. Rutherford,et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. , 1997, Journal of vascular surgery.
[19] Takayuki Asahara,et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.
[20] P. Desgranges,et al. The Management and Outcome of Critical Limb Ischaemia in Diabetic Patients: Results of a National Survey , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[21] J. Isner,et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. , 1994, Circulation.
[22] T. Schroeder,et al. Epidemiology of leg amputation: The influence of vascular surgery , 1994, The British journal of surgery.
[23] C. Sherbourne,et al. The RAND 36-Item Health Survey 1.0. , 1993, Health economics.
[24] N. D. Luccia,et al. Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. , 1992, Journal of Vascular Surgery.
[25] R. Rutherford,et al. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. , 1991, Journal of vascular and interventional radiology : JVIR.
[26] M. Salimans,et al. Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.
[27] Brian H Annex,et al. Claudication of Vascular Endothelial Growth Factor 121 in Patients With Disabling Intermittent Disease : A Phase II Randomized , Double-Blind , Controlled Study of Adenoviral Delivery Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial , 2003 .
[28] I. Hallberg,et al. A 1-year follow-up quality of life study after hemodynamically successful or unsuccessful surgical revascularization of lower limb ischemia. , 2001, Journal of vascular surgery.